These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1600394)

  • 1. Age-dependent regeneration of plasma proteins after donor plasmapheresis.
    Matthes G; Pawlow I; Ziemer S
    Infusionsther Transfusionsmed; 1992 Feb; 19(1):29-31. PubMed ID: 1600394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-dependent regeneration of plasma proteins after donor plasmapheresis.
    Matthes G; Pawlow I; Ziemer S
    Beitr Infusionsther; 1992; 30():186-9. PubMed ID: 1284703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach to increasing inventory with the current panel: increasing donation frequency by asking for a different blood product.
    Bagot KL; Masser BM; White KM
    Transfusion; 2015 Jun; 55(6):1294-302. PubMed ID: 25652648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Substitution of plasma proteins following the termination of plasmapheresis. 3].
    Smálik S; Strzínek M; Moscovic F
    Bratisl Lek Listy; 1971; 56(6):681-8. PubMed ID: 4110094
    [No Abstract]   [Full Text] [Related]  

  • 5. [Demography and donation frequencies of blood and plasma donor populations in Germany. Update 2010 and 5-year comparison].
    Ritter S; Hamouda O; Offergeld R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):914-22. PubMed ID: 22842884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Side effects and risk factors of various plasma donation methods].
    Ullrich H; Wiebecke D; Keller F
    Beitr Infusionsther; 1991; 28():77-81. PubMed ID: 1725664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of plasmapheresis on blood pressure in voluntary plasma donors.
    Rosa-Bray M; Wisdom C; Marier JF; Mouksassi MS; Wada S
    Vox Sang; 2015 Jan; 108(1):11-7. PubMed ID: 25169580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent source plasma donors are not at risk of iron depletion: the Ferritin Levels in Plasma Donor (FLIPD) study.
    Schreiber GB; Brinser R; Rosa-Bray M; Yu ZF; Simon T
    Transfusion; 2018 Apr; 58(4):951-959. PubMed ID: 29520799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
    Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
    Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of donation frequency on donor health in blood donors donating plasma by plasmapheresis: study protocol for a randomized controlled trial.
    Haugen M; Magnussen K; Aarsland TE; Nissen-Meyer LSH; Strand TA
    Trials; 2024 Mar; 25(1):175. PubMed ID: 38468338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the plasmapheresis donor in a voluntary, nonremunerated environment.
    Bove LL; Bednall T; Masser B; Buzza M
    Transfusion; 2011 Nov; 51(11):2411-24. PubMed ID: 21564104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building a flexible, voluntary donation panel: an exploration of donor willingness.
    Bagot KL; Masser BM; Starfelt LC; White KM
    Transfusion; 2016 Jan; 56(1):186-94. PubMed ID: 26408074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observation of the changes of plasma proteins after long term plasmapheresis.
    Grgicević D; Pistotnik M; Pende B
    Dev Biol Stand; 1980; 48():279-86. PubMed ID: 6168506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
    Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
    Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electrophoretic control of serum proteins in donors designated for plasmapheresis. Initial evaluation of the analysis of 3500 donors].
    Fine JM; Marneux M; Sayarath V
    Rev Fr Transfus Immunohematol; 1985 May; 28(2):125-36. PubMed ID: 4023543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of 4 plasmapheresis procedures].
    Wieding JU; Ullrich H; Neumeyer H
    Beitr Infusionsther; 1991; 28():65-76. PubMed ID: 1725662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma fractionation in England and Wales.
    Vallet L
    Vox Sang; 1972; 23(1):58-60. PubMed ID: 4628157
    [No Abstract]   [Full Text] [Related]  

  • 18. [Demography and donation frequencies of blood and plasma donor populations in Germany].
    Ritter S; Willand L; Reinhard B; Offergeld R; Hamouda O
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Aug; 51(8):915-25. PubMed ID: 18787870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gone, but haven't forgotten: insights on plasmapheresis donation from lapsed donors.
    Thorpe R; Nguyen L; Masser BM; Van Dyke N; Davison TE
    Vox Sang; 2021 Mar; 116(3):281-287. PubMed ID: 32966699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor safety in an individualized plasmapheresis program - Results of an interim analysis.
    Taborski U; Laitinen T
    Transfus Apher Sci; 2022 Oct; 61(5):103446. PubMed ID: 35461780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.